President Bio-den? Executive Order Highlights Value Of Biotech – But Doesn’t Change Pricing Message

The White House is playing up a new initiative to support ‘biotechnology and biomanufacturing.’ The focus on innovation is always a welcome theme – but it does not signal any change in the emphasis on cutting drug pricing in the Biden Administration.